Vivani Medical, Inc. (VANI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92854B1098
Vivani Medical, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -27.56 m USD |
| EBIT | -26.61 m USD |
| Net income | -26.61 m USD |
| Diluted EPS – continuing operations | -0.43 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
More stocks
- CHA Vaccine Institute Co. Ltd. (261780.KQ)
- KP Tissue Inc (KPT.TO)
- PCC Exol SA (PCX.WA)
- Agabang&Company (013990.KQ)
- Ying Han Technology Co Ltd (4562.TW)
- Seer, Inc. (SEER)
- CS BEARING Co.Ltd (297090.KQ)
- QumulusAI, Inc. Common Stock (QMLS)
- Sand Nisko Capital Bhd (7943.KL)
- Roadzen Inc. (RDZN)
- INITECH Co. Ltd (053350.KQ)
- Scorpio Gold Corp (SGN.V)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.